Living Cell Technologies

Targeting Huntington's Disease, Stroke, Type 1 Diabetes and Haemophilia

Archive

June 5, 2008

LCT Expands Diabetes Clinical Trial

>more

June 3, 2008

LCT Lists on International OTCQX

>more

May 21, 2008

LCT interviewed by New Zealand TV program, Close Up

>video

May 12, 2008

LCT presents encapsulation technology at conference

>more

May 8, 2008

LCT features on Channel Ten News

>more

>video

May 8, 2008

LCT prepares to list on international OTCQX

>more

News

New Zealand Herald Article - Pig cell treatment may start again
By Martin Johnston
August 25, 2006

Experimental pig-cell transplants into diabetics may resume after a 10-year ban caused by a disease scare - if health authorities approve.

Professor Bob Elliott halted a ground-breaking trial injecting type 1 diabetes sufferers with insulin-producing cells from pig pancreases in 1996 because of fears that humans could be infected by pig viruses.

Yesterday, the company of which he is medical director, Living Cell Technologies, announced that it had applied to medical regulator Medsafe to start a new human trial using an improved version of the same idea.

What is xenotransplantation?
The use of living animal cells, tissues or organs in human therapeutics. >more

What is DiabeCell?
DiabeCell is a porcine pancreatic cell product for the treatment of insulin-dependent diabetes. >more

What is NeurotrophinCell?
A choroid plexus (brain) cell product with the potential to treat diseases of the nervous system such as Huntington's disease and stroke. >more

What is LCT's encapsulation technology?
The living cells are covered in a seaweed-derived coating (alginate encapsulation) to form capsules which eliminate the
need for toxic immunosuppressant drugs and allow the release of beneficial factors. >more

	Home Contact Sitemap Legals Privacy
graphic design and website design - PDF Communications Ltd